Incidence and hierarchy of complications seen during long term follow up in cirrhotic patients according to aetiology
| HCV+/HBsAg− (n = 254) | HCV−/HBsAg+ (n = 43) | HCV+/HBsAg+ (n = 15) | |
|---|---|---|---|
| Overall incidence | |||
| At least one complication | 78 (30.7%) | 15 (34.8%) | 8 (53.3%) |
| HCC | 52 (20.5%) | 6 (13.9%) | 7 (46.7%) |
| Ascites | 45 (17.7%) | 10 (23.2%) | 6 (40.0%) |
| Bleeding | 12 (4.7%) | 1 (2.3%) | 0 |
| Encephalopathy | 5 (1.9%) | 1 (2.3%) | 0 |
| Progression of Child stage | 46 (18.1%) | 9 (20.9%) | 7 (46.7%) |
| Liver related death | 42 (16.3%) | 9 (20.9%) | 7 (46.7%) |
| Hierarchy | |||
| First event occurring | |||
| HCC | 47 (18.5%) | 6 (13.9%) | 6 (40.0%) |
| Ascites | 24 (9.4%) | 8 (18.6%) | 2 (13.3%) |
| Bleeding | 5 (1.9%) | 0 (0%) | 0 (0%) |
| Encephalopathy | 2 (0.8%) | 1 (2.3%) | 0 (0%) |